Lobbyists for independent drugstores are promoting measures that would increase insurance premiums for working families, seniors and the disabled, writes PCMA President and CEO Mark Merritt in Roll Call. Merritt says drug costs can be reduced by creating a pathway for getting biogenerics to market, eliminating hurdles to home delivery of prescription drugs and ridding Medicare of "protected classes" rules.

Related Summaries